The Prague Post - Once-taboo ketamine booms for US at-home mental care

EUR -
AED 4.237925
AFN 72.121544
ALL 94.935089
AMD 425.165269
ANG 2.066121
AOA 1059.336154
ARS 1653.936124
AUD 1.649552
AWG 2.080015
AZN 1.961994
BAM 1.954455
BBD 2.32514
BDT 141.702499
BGN 1.927022
BHD 0.435402
BIF 3450.540733
BMD 1.153961
BND 1.486477
BOB 7.977545
BRL 5.992565
BSD 1.154426
BTN 109.981801
BWP 15.677281
BYN 3.177714
BYR 22617.635458
BZD 2.321802
CAD 1.609037
CDF 2626.415545
CHF 0.922672
CLF 0.026848
CLP 1056.658891
CNY 7.81549
CNH 7.825102
COP 4108.585798
CRC 529.435711
CUC 1.153961
CUP 30.579966
CVE 110.19109
CZK 24.187195
DJF 205.08239
DKK 7.474563
DOP 67.353656
DZD 154.23035
EGP 59.794105
ERN 17.309415
ETB 186.117245
FJD 2.566697
FKP 0.861905
GBP 0.86333
GEL 3.058303
GGP 0.861905
GHS 13.448805
GIP 0.861905
GMD 84.238702
GNF 10113.216666
GTQ 8.799945
GYD 241.52486
HKD 9.041919
HNL 30.863299
HRK 7.537093
HTG 150.996104
HUF 356.809345
IDR 20677.019257
ILS 3.425487
IMP 0.861905
INR 110.370426
IQD 1512.359389
IRR 1586898.30836
ISK 143.402686
JEP 0.861905
JMD 182.294568
JOD 0.818129
JPY 185.211313
KES 149.334265
KGS 100.912851
KHR 4645.823473
KMF 492.741659
KPW 1038.397856
KRW 1758.884682
KWD 0.357001
KYD 0.962042
KZT 563.154949
LAK 25420.618951
LBP 103378.616089
LKR 384.432146
LRD 210.106342
LSL 19.126771
LTL 3.407346
LVL 0.69802
LYD 7.369833
MAD 10.690244
MDL 20.092262
MGA 4842.6679
MKD 61.67086
MMK 2422.068493
MNT 4126.891471
MOP 9.318129
MRU 46.160039
MUR 55.240349
MVR 17.839712
MWK 2001.831271
MXN 20.095365
MYR 4.700111
MZN 73.734387
NAD 19.126771
NGN 1570.356588
NIO 42.48077
NOK 10.920855
NPR 175.970682
NZD 1.990808
OMR 0.443686
PAB 1.154411
PEN 3.925099
PGK 5.131469
PHP 70.860703
PKR 321.251324
PLN 4.252635
PYG 7130.155734
QAR 4.209149
RON 5.235292
RSD 117.392842
RUB 83.370827
RWF 1693.542061
SAR 4.332469
SBD 9.284277
SCR 15.279886
SDG 692.954513
SEK 10.980637
SGD 1.48625
SHP 0.861548
SLE 28.444832
SLL 24197.987467
SOS 659.748904
SRD 43.113136
STD 23884.662712
STN 24.483578
SVC 10.101225
SYP 127.549729
SZL 19.121926
THB 38.074955
TJS 10.799476
TMT 4.050403
TND 3.388427
TOP 2.778461
TRY 53.262572
TTD 7.835609
TWD 36.54006
TZS 3023.381254
UAH 52.019607
UGX 4346.084909
USD 1.153961
UYU 46.76782
UZS 13916.665543
VES 654.264951
VND 30372.25333
VUV 137.889437
WST 3.167617
XAF 655.508804
XAG 0.018528
XAU 0.000285
XCD 3.118637
XCG 2.080568
XDR 0.815649
XOF 655.497451
XPF 119.331742
YER 275.392172
ZAR 19.135563
ZMK 10387.03422
ZMW 20.000325
ZWL 371.574969
  • RBGPF

    2.0500

    60.72

    +3.38%

  • CMSC

    -0.0100

    22.3

    -0.04%

  • CMSD

    0.0100

    22.29

    +0.04%

  • RYCEF

    -0.2300

    16.49

    -1.39%

  • NGG

    -0.7000

    80.38

    -0.87%

  • BCE

    0.1300

    24.71

    +0.53%

  • GSK

    -0.0800

    51.17

    -0.16%

  • RIO

    -2.3600

    99.06

    -2.38%

  • RELX

    -0.9600

    33.98

    -2.83%

  • AZN

    -4.4700

    178.96

    -2.5%

  • BTI

    1.1700

    61.12

    +1.91%

  • JRI

    0.1400

    12.86

    +1.09%

  • VOD

    0.3800

    15.05

    +2.52%

  • BCC

    -1.7000

    68.31

    -2.49%

  • BP

    0.2800

    42.95

    +0.65%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

N.Simek--TPP